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Abstract
Introduction: Breast cancer is the most common malignancy in women. 
It frequently metastasizes to bones, lungs and liver. Although rare, skin 
metastasis may also take place. It may also be the presenting feature of 
initial or recurrent breast cancer. The assessment of recurrent metastatic 
disease involving skin after mastectomy can be challenging because of 
the benign-appearing clinical presentation. The purpose of this case 
series was to explore the clinical and radiological presentation of skin 
metastasis in patients of breast cancer. Materials and Methods: This is 
a retrospective case series of breast cancer patients with skin lesions on 
chest and abdomen at the time of initial presentation, or post-treatment 
such as, after mastectomy or breast conservation therapy; who underwent 
various radiological investigations including mammography, ultrasound 
scan, computed tomography (CT) scan and magnetic resonance imaging 
from 1  May  2018 to 30  September 2019 at Shaukat Khanum Memorial 
Cancer Hospital and Research Centre, Pakistan. Results: A total of eight 
cases were identified, out of which seven were females. The most common 
presentation consisted of the presence of metastatic nodules which were 
seen in 62.5% (five out of eight) of the patients. Other features consisted 
of erythematous or plaque-like skin thickening on clinical examination, 
increased density with indistinct margins seen on a mammogram and 
diffuse oedematous changes in the skin with small irregular mass or 
infiltration into subcutaneous tissues were visualised on ultrasound and CT 
studies. Conclusion: Skin metastasis from breast cancer most commonly 
presents as nodules, although rarely they may present as plaques or diffuse 
skin thickening. Awareness of diverse manifestations of skin metastasis is 
of utmost importance in early diagnosis and management.
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Skin metastasis from primary visceral malignancies is 
an uncommon presentation.[1] The overall incidence 
of skin metastasis is 5.3%.[2] Skin metastasis is more 
frequently seen in breast cancer than in any other 
visceral malignancy in women.[1] The incidence 
of breast carcinoma cutaneous manifestation 
is 23.9%.[1] The most common sites of breast 
carcinoma skin manifestation are the chest wall, 
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During the hospital visit, patients underwent a 
comprehensive clinical assessment comprising 
of a complete history, physical examination, 
radiological imaging, interventional procedures and 
pathological analysis. For radiological assessment, 
all patients underwent ultrasound examination of 
breasts or mastectomy scar site using 7.5–10 MHz 
linear array transducer Toshiba Aplio XG, Toshiba 
Xario 100 and Toshiba Aplio 500. In addition, 
where indicated, mammography was performed on 
dedicated mammographic equipment, consisting 
of Senographe Essential (GE) and Mammomat 
Inspiration (Siemens),  acquiring standard 
mediolateral oblique and craniocaudal views of the 
breasts. Likewise, computerised tomography (CT) 
scan of chest, abdomen and pelvis with contrast was 
conducted using Prime SP Aquilion Scanner (160 
slices). For contrast, 1.5–1.67  ml/kg of iodinated 
intravenous contrast medium was injected at a rate 
of 1.5–2 ml/s by a Medrad-Salient Power Injector, 
with a scan delay of 70 s after the onset of injection. 
Typical imaging parameters were 120  kVp, 150 
mAs and 5 mm slice thickness with a pitch of 1.2. 
Similarly, dynamic contrast-enhanced MRI study 
of breasts was performed using Ingenia 1.5-T 
(Philips) with a dedicated breast surface coil, non-
contrast axial T1, STIR and post-contrast dynamic 
enhanced axial and sagittal T1 Fat Sat images were 
acquired after IV administration of contrast medium 
(0.1 mmol/kg gadovist). The diagnosis was made 
based on findings of cytology/histopathology of 
ultrasound-guided fine-needle aspiration (FNA)/
core biopsy.
Staging of the tumour was based on clinical 
examination, cytology/histopathology and 
radiological findings (as per American Joint 




A 68-year-old woman presented with left breast 
diffuse skin thickening for 2  years. On clinical 
examination, there was a diffuse firm mass extending 
abdomen and back, but they can occur at the 
extremities and in the head/neck region.[3]
Skin lesions can be the first sign for the initial 
occurrence of the breast cancer. They have a 
wide range of clinical manifestations, ranging 
from painless single or multiple hard nodules to 
induration and oedema of the skin of the breast, 
known as the orange-peel appearance (peau 
d’orange).[3] Peau d’orange of breast is considered 
to be a common sign for inflammatory breast 
cancer (IBC). However, it may present in various 
other benign conditions as well, such as cellulitis or 
lymphedema.[3,4] IBC is an aggressive form of breast 
cancer. It often has systemic manifestations and a 
poor prognosis. Therefore, early diagnosis and 
prompt intervention are crucial for management.[4] 
Conversely, skin lesions can be one of the initial 
signs for the recurrence of breast cancer.[5] This is 
considered clinically to be a diagnostic challenge 
because clinical signs of skin metastasis share 
close similarity to the skin changes that take place 
after antineoplastic therapy (surgery or radiation 
therapy).[5] To improve the understanding of skin 
lesions associated with breast cancer, the present 
study was conducted to explore the clinical and 
radiological presentations of skin metastasis in 
patients of breast cancer.
Materials and Methods
A retrospective electronic medical chart review 
was conducted of breast cancer patients with skin 
lesions on the chest and abdomen at the time of 
initial presentation, or post-treatment such as, 
after mastectomy or breast conservation therapy, 
who underwent various radiological investigations 
such as mammography, ultrasound, computed 
tomography (CT) scan, or magnetic resonance 
imaging (MRI) from 1 May 2018 to 30 September 
2019 at Shaukat Khanum Memorial Cancer 
Hospital and Research Centre, Pakistan. Breast 
cancer patients without skin lesions were excluded 
from the study. This study was approved by the 
Institutional Review Board of Shaukat Khanum 
Memorial Cancer Hospital and Research Centre 
(03-07-19-01).
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from the inframammary fold to left hypochondrium, 
left flank and epigastric region, which was 
inseparable from the overlying erythematous skin.
She underwent a mammogram and an ultrasound 
of the left breast. Her mammogram showed an 
indistinct increased density mass in the lower 
central aspect in the left breast [Figure 1.1a and b]. 
On ultrasound, there was diffuse skin thickening 
with infiltration into subcutaneous tissues in the left 
breast involving the inframammary fold extending 
into the anterior abdominal wall [Figure  1.2]. 
Following the scans, the patients had an ultrasound-
guided biopsy from the subcutaneous mass and 
wedge biopsy of the skin. These were positive 
for invasive lobular carcinoma (ILC)  -  Grade  II. 
Furthermore, wedge biopsy histopathological 
sample suggested that tumour was extending 
into the dermis. The patients also underwent CT 
chest, abdomen and pelvis study with contrast. It 
showed extensive soft-tissue thickening in the left 
breast, inframammary fold extending along the 
length of the anterior abdominal wall, involving the 
rectus sheath and the anterior abdominal muscles, 
with significant overlying skin thickening and 
subcutaneous oedema. The underlying peritoneal 
lining was also thickened, with fat stranding in the 
greater omentum and neovascularity in the anterior 
abdominal wall. Fat stranding was noted in the left 
axilla as well, with soft tissue involving the serratus 
anterior, left shoulder girdle muscles and latissimus 
dorsi muscle [Figure 1.3a and b].
Based on the medical history, clinicohistopathological 
ana lys i s  and  rad io log ica l  f ind ings ,  the 
multidisciplinary team (MDT) decided that the 
patients should be started on hormonal therapy 
(letrozole 2.5 mg once a day). The patients did not 
come back to the hospital for follow-up.
Case 2
A 36-year-old woman presented with the right 
breast lump for 6 months. Her clinical examination 
was significant for a fixed 3 cm lump at 6 o’clock 
and multiple enlarged right axillary lymph nodes.
Her mammogram showed an increased density 
mass in the right lower central breast and her right 
breast ultrasound showed an irregular hypoechoic 
infiltrative mass in the right breast at 5 o’clock. In 
addition, there was a hypoechoic dermal nodule 
present at 6 o’clock, measuring 7 mm at a distance 
of 4 mm from the main mass [Figure 2.1]. The right 
axilla showed multiple enlarged lymph nodes 
and an irregular mass measuring 31 mm ×26 mm. 
Figure  1.2: Greyscale images of the left breast are 
demonstrating diffuse skin thickening with infiltration 
into subcutaneous tissues (red arrow) in the left breast 
involving the inframammary fold extending into the 
anterior abdominal wall
Figure 1.1: (a and b): Craniocaudal (a) and mediolateral 
oblique (b) views of left breast show increased density 
mass with indistinct margins (shown as red*) in the lower 
central aspect. No grouped suspicious microcalcifications 
are visualised
a b
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Ultrasound-guided core biopsies were performed 
for the right breast 5 o’clock and the right axillary 
masses. The histopathological analyses showed 
the presence of invasive ductal carcinoma (IDC) – 
Grade III in both masses. Furthermore, the patients 
underwent ultrasound-guided FNA in the right 
axillary lymph node and right breast 6 o’clock skin 
nodule. FNA of the right lymph node was positive 
for metastatic carcinoma, and FNA for breast nodule 
was significant for mammary carcinoma. CT chest, 
abdomen and pelvis with contrast were performed 
for the metastatic workup. It was notable for the 
presence of a right breast mass with ipsilateral 
axillary lymphadenopathy. A small skin nodule was 
also noted at 6 o’clock [Figure 2.2]. There was no 
evidence for distant metastatic disease.
The MDT agreed to start the patients on neoadjuvant 
chemotherapy followed by right mastectomy. 
Breast conservation was not considered as a 
treatment option due to the presence of metastatic 
skin nodule which upstaged the disease to T4b/
Stage III.
Case 3
A 58-year-old man presented with the right 
breast lump for 5 years with blood-stained nipple 
discharge. Clinical examination was significant for a 
4 cm right breast retro-areolar lump with ulceration 
of the overlying skin and nipple. In addition, 
another nodular 1 cm mass was palpable. This was 
2 cm medial to the main mass.
Mammogram of this patients showed a high-density 
spiculated mass in the retroareolar region in the 
right breast with overlying skin tethering, thickening 
and nipple retraction. A circumscribed high-density 
mass was also seen in the upper outer quadrant. 
Furthermore, a suspicious high-density irregular 
mass was seen near the axillary tail  [Figure 3.1a and b] 
and few small lymph nodes were noted in the right 
Figure  2.1: Greyscale ultrasound images of the right 
breast show a hypoechoic dermal nodule (red arrow) at 
6 o’clock, measuring 7 mm at 4 mm from the main mass 
(blue arrow)
Figure  2.2: Soft-tissue window of the axial image of 
contrast-enhanced CT through chest showing small skin 
nodule (red arrow) at 6 o’clock
Figure 1.3: (a and b): Sagittal (a) and axial (b) images 
of contrast-enhanced CT through chest, abdomen and 
pelvis in soft-tissue window show extensive soft-tissue 
thickening in the left breast along the inframammary fold 
extending along the length of the anterior abdominal 
wall, involving the rectus sheath and the anterior 
abdominal muscles (shown as red*). The underlying 
peritoneal lining was also thickened, with fat stranding 
in the anterior omentum (blue arrow)
ba
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axilla. Correlative ultrasound scan of breast showed 
an irregular hypoechoic mass in the right breast 
retroareolar region with the surrounding area of 
architectural distortion. It was inseparable from the 
overlying skin. There was a hyperechoic nodule in 
the skin/superficial tissues, measuring 9 mm at 2 
o’clock, at a distance of 35 mm from the main mass 
[Figure  3.2]. Another irregular hypoechoic mass 
was observed at 9 o’clock, at a distance of 35 mm 
from the main mass. Few adjacently placed and 
similar-appearing hypoechoic masses were noted 
near the axillary tail. Ultrasound-guided biopsy was 
performed for the right breast retroareolar main 
mass and 9 o’clock and axillary tail satellite masses. 
The histopathological analysis showed IDC – Grade II 
in both of the breast masses, and the lymph node 
in axillary tail mass was significant for metastatic 
carcinoma. Ultrasound-guided FNA from the right 
breast skin mass at 2 o’clock revealed mammary 
carcinoma on cytopathology.
CT chest and abdomen with contrast showed right 
breast retroareolar mass with adjacent 10 mm soft-
tissue nodule and ipsilaterally enlarged axillary 
lymph nodes along with widespread metastatic lung 
disease (Figure 3.3a and b). Nuclear medicine bone 
scintigraphy study showed increased radiotracer 
uptake involving the right sixth rib near the 
costovertebral junction with underlying sclerotic 
change. This was concerning for osseous metastasis.
The MDT recommended the patients to undergo 
systemic chemotherapy, followed by a CT scan 
to reassess the extent and severity of the disease. 
A  CT chest and abdomen were performed after 
6 months of completing systemic chemotherapy. 
It showed partial interval treatment response 
according to RECIST (Response Evaluation Criteria 
in Solid Tumours) criteria.[7]
Figure  3.2: Greyscale ultrasound image of the right 
breast showing a hyperechoic nodule in the skin 
measuring 9 mm at 2 o’clock
Figure 3.1: (a and b): Craniocaudal (a) and mediolateral 
oblique (b) views of right breast showing a high-density 
spiculated mass (shown as red*) in the retroareolar region 
right breast with overlying skin tethering, thickening and 
nipple retraction. A  circumscribed high-density mass 
is also seen in the upper outer quadrant (blue arrow). 
Suspicious high-density irregular mass is also visualised 
near the axillary tail (shown by green*)
a b
Figure 3.3: (a and b): Axial (a) and sagittal (b) images 
of soft-tissue window of contrast-enhanced CT chest 
showing right breast 02:00 skin nodule (blue arrow) 
and retroareolar spiculated mass (shown as red*) with 
overlying nipple and areolar complex retraction
a b
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Case 4
A 54-year-old female presented with history of 
right breast lump for 2 months. Her examination 
was significant for the presence of a 3  cm lump 
with overlying skin involvement at 12 o’clock, and 
multiple palpable right axillary lymph nodes.
She underwent bilateral mammographic studies 
with standard views. On the right side, there was 
a spiculated mass in the upper outer quadrant of 
the breast with overlying skin tethering. Another 
spiculated mass was seen in the upper outer 
quadrant in the posterior aspect. The right axillary 
region was clear. On the left side, the breast 
showed two spiculated masses in the upper inner 
quadrant [Figure 4.1a-d].
Her ultrasound scan of breasts showed an irregular 
hypoechoic spiculated mass in the right breast at 
a 12 o’clock, measuring 18 mm × 22 mm, which 
appeared inseparable from overlying skin. An 
irregular hyperechoic dermal nodule, measuring 
9  mm was seen at a 10 o’clock, at a distance of 
6 mm from the 12 o’clock mass [Figure 4.2a and b]. 
The right axillary region had multiple enlarged 
suspicious lymph nodes. The left breast showed 
two small hypoechoic masses at 10 o’clock and 9 
o’clock, measuring 5 mm and 4 mm each.
The patients underwent ultrasound-guided 
biopsy of the bilateral breast masses. These were 
positive for Grade II-ILC. In addition, the patients 
completed ultrasound-guided FNA for the right 
breast dermal nodule and the right axillary lymph 
node. The cytopathology analyses of these lesions 
were significant for the presence of malignant cells 
in the right breast dermal nodule and metastatic 
carcinoma in the right axillary lymph node.
The MDT recommendations for this patients were 
to complete neoadjuvant chemotherapy followed 
by a right mastectomy, and left breast wire-guided 
localised excision of the two masses.
Case 5
A 63-year-old woman presented with palpable 
nodules along the left chest wall on the previous 
surgery scar site along with palpable right 
axillary lymph nodes. She had been treated 
with breast conservation therapy for the left 
breast IDC Grade III 5 years ago. She had a local 
recurrence 2  years ago, for which neoadjuvant 
Figure 4.1: (a-d): Mediolateral oblique (MLO) (a) and craniocaudal (CC) (c) views of the right breast show a spiculated 
mass (blue arrow) in the upper outer quadrant of the right breast with overlying skin tethering. Another spiculated 
mass (red arrow) is also seen in the upper aspect on MLO view in the posterior aspect. MLO (b) and CC (d) views of 
the left breast show two spiculated masses (shown by green*) in the upper inner quadrant
ba dc
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chemotherapy was administered followed by left 
breast mastectomy.
Her mammogram of the right breast showed 
skin thickening with enlarged right axillary lymph 
nodes [Figure  5.1]. She had a dynamic breast 
MRI scan of the breasts, which suggested small 
enhancing masses with diffusion restriction, along 
the mastectomy scar and an enlarged contralateral 
right axillary lymph node [Figure 5.2a-d]. MRI scan 
was followed by an ultrasound-guided FNA from 
left mastectomy scar site nodules and a core biopsy 
of the right axillary lymph node and results were 
positive for the presence of malignant cells and 
metastatic carcinoma, respectively.
The MDT advised systemic chemotherapy 
for this patients. However, the patients was 
unable to complete the course of therapy due to 
multiple systemic side effects. She was placed on 
exemestane (25  mg once a day). Her follow-up 
ultrasound breast and CT of chest, abdomen and 
pelvis showed regression of disease (as per RECIST 
criteria[7]) and there was no evidence of metastasis.
Case 6
A 35-year-old woman presented with fever, left 
chest wall skin thickening and erythema extending 
into the right breast and left flank for 2  months 
after completion of radiotherapy to the left chest 
wall. She had a history of left breast multifocal IDC 
Grade III, for which neoadjuvant chemotherapy was 
administered and modified radical mastectomy 
(MRM) was performed subsequently. Radiotherapy 
was also completed after the surgery. Initially, 
the aforementioned presenting symptoms and 
clinical findings were considered as post-radiation 
inflammatory changes and she was given anti-
inflammatory medication; however, after no 
significant improvement in symptoms over 
corresponding weeks, the patients underwent a 
series of testing to rule out local recurrence of the 
disease.
Ultrasound of the left chest wall showed diffuse 
oedematous changes involving the skin and 
subcutaneous tissues along with the mastectomy 
Figure 4.2: (a): Greyscale ultrasound images showing (a) irregular hypoechoic spiculated mass in the right breast 
12 o’clock (blue arrow), which appears inseparable from overlying skin, (b) an irregular hyperechoic dermal nodule 
(red arrow), seen at 10 o’clock in the right breast
a b
Figure 5.1: (a and b): (a) Mediolateral oblique and (b) 
craniocaudal views of the right breast showing interval 
development of the right breast skin thickening (blue 
arrow) and enlarged right axillary lymph nodes (shown 
by red*)
ba
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site along with the extension to the left lateral 
chest wall. Irregular masses, measuring 9 mm in 
maximum thickness, were seen along with the 
scar site and left axilla [Figure 6.1a]. Furthermore, 
the enlargement of contralateral right axillary 
lymph nodes was appreciated. An ultrasound-
guided biopsy [Figure 6.1b] was performed for the 
irregular mass along with the mastectomy scar site. 
It was positive for IDC – Grade III. An ultrasound-
guided FNA was performed for the enlarged right 
axillary lymph node as well as from the irregular 
mass in the left axilla, and cytopathological analyses 
suggested the presence of metastatic carcinoma.
CT chest abdomen and pelvis with contrast 
were performed and it showed indistinct 
enhancement/thickening along the left mastectomy 
scar site/anterior chest wall and subcutaneous 
nodular thickening along the left lateral chest 
wall [Figure  6.2a and b]. In addition, there were 
bilateral pleural effusions, with patchy multifocal 
ground-glass opacities and interstitial septal 
thickening associated with mediastinal and hilar 
lymphadenopathy.
Based on the immediate radiological and 
pathological findings, MDT recommended the 
patients to be started on systemic chemotherapy. 
Follow-up imaging has not yet been performed.
Case 7
A 54-year-old female presented with a small 1.5 cm 
skin based ulcerated mass at the medial end 
of the infra-mammary fold. She had a history of 
lumpectomy done for the right breast IDC Grade II, 
followed by chemotherapy and radiotherapy 
14 years ago.
Bilateral breast mammogram was performed 
with standard views which showed post-surgical 
architectural distortion in the lower central aspect 
Figure 5.2: (a-d): (a and b) Dynamic contrast enhanced magnetic resonance imaging (MRI) breasts showing enhancing 
nodules (blue arrow) along left mastectomy scar site, with evidence of restricted diffusion, (c) same lesion in a diffusion-
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(skin based nodule was not covered due to its 
location) [Figure 7.1a and b]. Ultrasound scan of 
breasts showed a circumscribed hypoechoic mass 
at 05:00 position near the inframammary fold, in 
the dermal planes measuring about 16 mm ×6 mm 
and extending into the subcutaneous tissues. An 
enlarged intramammary lymph node was seen near 
the axillary tail [Figure  7.2a and b]. The patients 
underwent ultrasound-guided FNA of the dermal 
nodule and the intramammary lymph node. The 
cytopathological analyses were significant for 
mammary carcinoma and reactive lymphoid 
hyperplasia, respectively.
CT chest, abdomen and pelvis with contrast were 
performed that showed changes of lumpectomy 
and a heterogeneously enhancing small soft-tissue 
mass involving the lower inner quadrant of the right 
breast with overlying skin infiltration. The right axilla 
showed changes of axillary lymph node dissection 
with no abnormal soft-tissue mass noted near the 
axillary scar site. Furthermore, there was a large 
right-sided pleural effusion along with extensive 
heterogeneously enhancing pleural based masses, 
concerning for metastatic disease [Figure  7.3a]. 
Enlarged nodal masses were noted in the right 
internal mammary station, pretracheal and right 
paratracheal region [Figure 7.3b].
The MDT decision was to start the patients on 
systemic chemotherapy. Follow-up imaging has 
not yet been performed.
Figure 6.2: (a and b): Axial slices of contrast-enhanced CT 
scan through the chest and upper abdomen soft-tissue 
window showing indistinct enhancement/thickening 
along with the left modified radical mastectomy scar 
site/anterior chest wall (red arrow) and subcutaneous 
nodular thickening along left lateral chest wall (blue 
arrow). Bilateral pleural effusions (red*) also seen
a b
Figure  7.1: (a and b): (a) Mediolateral oblique and 
(b) craniocaudal views of the right breast, showing 
post-surgical architectural distortion in the lower central 
aspect and mild skin thickening (skin based nodule not 
covered due to its location)
ba
Figure 6.1: (a and b): (a) Greyscale ultrasound images of right mastectomy scar site showing diffuse oedematous 
changes involving the skin and subcutaneous tissues (blue arrow) along with the mastectomy site along with the 
extension to the left lateral chest wall. (b) Irregular mass (red arrow) along with the scar site and ultrasound-guided 
biopsy of this mass
a b
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Case 8
A 50-year-old female presented with rapid onset 
of rash on her left anterior chest, upper left arm 
and left axilla. She had a 1 day history of blister 
formation on the dorsal aspect of left-hand 
finger with high-grade fever. She had a history 
of left breast IDC Grade  II and was treated with 
neoadjuvant chemotherapy followed by left MRM 
and radiation therapy 2 years ago. On examination, 
there was erythema on the left anterior chest, left 
arm and left axilla. Clinical assessment was that this 
was either an allergic reaction or cellulitis.
Ultrasound showed localised collection with thick 
walls without any echogenic foci or septations 
or abnormal vascularity under the lateral end of 
left mastectomy scar representing post-surgical 
seroma [Figure 8]. Ipsilateral arm and axilla showed 
diffuse oedematous changes involving the skin and 
subcutaneous tissues. No radiologically suspicious 
axillary lymph nodes were seen. These findings 
were suggestive of cellulitis, and the patients was 
treated with systemic antibiotics for 2 weeks. Arm 
physiotherapy and exercises were also advised.
Patients reported to follow-up in the outpatient clinic 
after 2 weeks and was found to be asymptomatic 
with the resolution of redness and swelling at the 
scar site.
Discussion
Breast cancer is the most common primary 
malignancy that presents with  cutaneous 
metastasis.[1] Cutaneous metastasis is usually a sign 
of advanced breast cancer; rarely, it may be the first 
sign of undiagnosed breast cancer.[1] Moreover, 
patients may present years after diagnosis and 
treatment have been completed.[5] These skin 
lesions have variable clinical appearances and can 
be mistaken for benign skin lesions.
In a retrospective review by Mordenti et al., 
164  cases of skin metastasis from breast 
carcinoma were examined to determine the 
most common clinical and histopathological 
presentations.[9] Skin papules and/or nodules 
were the most common manifestation found in 
Figure 8: Greyscale ultrasound images show localised 
collection with thick walls without any echogenic foci or 
septations under the lateral end of left mastectomy scar 
representing seroma (shown by red*)
Figure 7.2: (a and b): (a) Greyscale ultrasound image 
shows a circumscribed hypoechoic mass (blue arrow) at 5 
o’clock near the inframammary fold, in the dermal planes, 
extending into the subcutaneous tissues. (b) Enlarged 
intramammary lymph node (red arrow) also seen near 
the axillary tail
a b
Figure  7.3: (a and b): (a) Contrast-enhanced CT 
through chest axial section soft-tissue window shows a 
small soft tissue mass (blue arrow) involving the lower 
inner quadrant of the right breast with overlying skin 
infiltration. Large right-sided pleural effusion along with 
the extensive heterogeneously enhancing pleural based 
masses (red arrow) is also noted. (b) Enlarged nodal mass 
is seen in the right internal mammary station (shown by 
red*) as well as in the paratracheal and right paratracheal 
region (shown by green*)
ba
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80% of patients, telangiectatic carcinomas were 
seen in 11%, erysipeloid carcinomas in 3%, ‘en 
cuirasse’ carcinomas in 3%, alopecia neoplastica 
in 2% and a zosteriform type in 0.8%.[9] In our case 
series, metastatic nodules were the most common 
presentation of CM, which was seen in five out of 
eight patients.
In the initial diagnostic workup of breast cancer 
patients, evidence of metastatic skin nodules or 
inflammatory carcinoma is very important while 
considering the surgical management of the 
disease. The presence of metastatic dermal nodules, 
in the absence of distant metastasis, is considered 
as the local advancement of the disease. It is staged 
as T4b, as per AJCC TNM 7th edition classification.[6] 
Regardless of the tumour size and involvement 
of the regional lymph nodes, the presence of 
skin involvement places any tumour into Stage III 
and it is considered a contraindication to breast 
conservation therapy.[4] Studies of neoadjuvant 
chemotherapy for breast conservation still typically 
exclude cases with cutaneous metastasis; similarly, 
some studies narrate that breast conservation is 
contraindicated when skin involvement exists in 
tumours of any size.[4]
There were two cases that presented with extensive 
diffuse skin thickening and erythema clinically 
resembling carcinoma erysipeloides or carcinoma 
en cuirasse. Our first case had skin lesions at the 
time of the initial presentation, while the sixth case 
was a treated breast cancer patients. Carcinoma 
erysipeloides (CE) is an uncommon but distinctive 
form of cutaneous metastasis that usually manifests 
clinically as a fixed erythematous patch or plaque 
resembling cellulitis or erysipelas. Al Ameer et 
al. reported a case of CE with underlying breast 
carcinoma, which was initially being treated as 
eczematous dermatitis for 2  months.[10] CE has 
rapid clinical onset and aggressive progression that 
requires prompt diagnosis and early management 
to improve survival. However, it often presents as a 
diagnostic challenge as it may be easily mistaken 
for other entities; these include mastitis, cellulitis, 
erysipelas, thrombophlebitis, venous congestion, 
allergic reactions, postsurgical lymphedema or 
hematoma, post-radiotherapy dermatitis, herpes 
zoster infection, primary squamous, or basal cell 
carcinoma.[11] Carcinoma en cuirasse is an unusual 
skin metastasis of breast cancer with diffuse 
carcinomatous cutaneous and subcutaneous 
infiltration that may affect the chest and abdomen, 
by extension.[8] Reich et al. have reported a case 
of carcinoma en cuirasse as an initial clinical 
manifestation of breast cancer in a woman with 
15-month history of asymptomatic, previously 
untreated erythematous and indurated skin lesions 
of the right chest.[12] Our eighth case had a similar 
clinical presentation of diffuse erythematous skin 
thickening involving mastectomy scar site, but 
imaging features were not favouring malignancy. 
This patients was followed up until she had 
complete resolution of symptoms, which occurred 
after a course of antibiotic treatment.
Diagnosis of cutaneous metastasis is very important 
in breast cancer patients for correct staging 
as well as a possibility of metastatic disease 
in patients presenting with cutaneous lesions 
over breast mimicking benign dermatological 
conditions. Disease relapse in post-surgery and/
or post-radiotherapy breast cancer patients may 
be confused with post-treatment cellulitis or 
inflammation. The imaging modalities, including 
mammography, ultrasound scan, CT and MRI aid 
in the detection of skin metastasis and in excluding 
possible benign causes. If there is any uncertainty 
regarding the aetiology of the cutaneous lesion, or 
no resolution with initial treatment, the threshold 
for a tissue diagnosis should be low for accurate 
diagnosis and treatment.
References
1. Navaratnam AV, Chandrasekharan S. Remote 
cutaneous breast carcinoma metastasis mimicking 
dermatitis. Indian J Dermatol 2015;60:106.
2. Krathen RA, Orengo IF, Rosen T. Cutaneous 
metastasis: A  meta-analysis of data. South Med J 
2003;96:164-7.
3. Helm TN, Lee TC. Dermatologic Manifestations 
of Metastatic Carcinomas Clinical Presentation, 
Medscape; 2019.
4. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, 
Outlaw ED, Strom EA, et al. Breast conservation after 
Journal Of Cancer & Allied Specialties 12
J Cancer Allied Spec 2020;6(1):12 Original Article
neoadjuvant chemotherapy. Cancer 2005;103: 689-95.
5. Virmani NC, Sharma YK, Panicker NK, Dash KN, 
Patvekar MA, Deo KS. Zosteriform skin metastases: 
Clue to an undiagnosed breast cancer. Indian J 
Dermatol 2011;56:726-7.
6. Edge SB. AJCC Cancer Staging Manual. 7th  ed. 
New York: Springer, American Joint Committee on 
Cancer; 2010.
7. Nishino M, Jagannathan JP, Ramaiya NH, Van den 
Abbeele AD. Revised RECIST guideline version 1.1: 
What oncologists want to know and what radiologists 
need to know. AJR Am J Roentgenol 2010;195:281-9.
8. Oliveira GM, Zachetti DB, Barros HR, Tiengo A, 
Romiti N. Breast carcinoma en Cuirasse--case report. 
An Bras Dermatol 2013;88:608-10.
9. Mordenti C, Peris K, Fargnoli MC, Cerroni L, 
Chimenti S. Cutaneous metastatic breast carcinoma. 
Acta Dermatovenerol 2000;9:143-8.
10. Al Ameer A, Imran M, Kaliyadan F, Chopra R. 
Carcinoma erysipeloides as a presenting feature of 
breast carcinoma: A case report and brief review of 
literature. Indian Dermatol Online J 2015;6:396-8.
11. Chow HT, Tran K, Millar EK, Lynch J, Murrell DF. 
Diverse presentations of carcinoma erysipelatoides 
from a teaching hospital in Australia. Case Rep 
Dermatol Med 2012;2012:134938.
12. Reich A, Samotij D, Szczęch J, Woźniak Z, 
Szepietowski J. Carcinoma en cuirasse as an initial 
manifestation of inflammatory breast cancer. Postepy 
Dermatol Alergol 2016;33:142-5.
Authorship Contributions
Conceived and designed the analysis: SR; Collected 
the data: SR; Contributed data or analysis tools: SR 
and MAN; Performed the analysis: N/A; Wrote the 
paper: SR and MAN.
